CLINICAL_TRIALS
trial_result
· 2025-10-01
Clinical Trial Update: Dose Finding Study of BI 836880 in Patients With Solid Tumors [Phase 1]
Summary
Phase 1 dose-finding study of BI 836880 in patients with solid tumors has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2025-10-01